Sat, Oct 25, 2014, 8:26 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

PROLOR Biotech, Inc. Message Board

  • john_j_315 john_j_315 Dec 17, 2012 2:28 PM Flag

    A history of underperformance

    04/08/2011 - Prolor president Shai Novik told "Globes" that the trial's results exceeded expectations, and could enable the company to move directly to a Phase III clinical trial. The Phase III trial will include 150-200 adults with growth hormone deficiency and take six months to prove the treatment's efficacy and twelve months to confirm its safety. "We're working hard to submit the trial application in the first quarter of 2012," he said.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 03/24/2010 - "Proceeds from the financing will enable us to reach Phase III trials of the human growth hormone. The money will be enough through mid-2012," said Novik. "During this period, we may already sign licensing agreements, which will generate more revenue."

      Sentiment: Hold

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.